These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22964310)

  • 1. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
    Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY
    Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
    Woodhall M; Çoban A; Waters P; Ekizoğlu E; Kürtüncü M; Shugaiv E; Türkoğlu R; Akman-Demir G; Eraksoy M; Vincent A; Tüzün E
    J Neurol Sci; 2013 Dec; 335(1-2):221-3. PubMed ID: 24045088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
    J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-MOG antibody in different types of immune-mediated optic neuritis].
    Kong XY; Peng JT; Liu LJ; Yan R; Zhang XJ
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1069-72. PubMed ID: 23336409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
    Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
    Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
    Mariotto S; Gajofatto A; Batzu L; Delogu R; Sechi G; Leoni S; Pirastru MI; Bonetti B; Zanoni M; Alberti D; Schanda K; Monaco S; Reindl M; Ferrari S
    Neurology; 2019 Nov; 93(20):e1867-e1872. PubMed ID: 31645473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein.
    Koç S; Şen S; Terzi Y; Kızılay F; Demir S; Bekar Aksoy D; Kurtuluş F; Bilge N; Idilman E; Uzunköprü C; Güngör S; Çilingir V; Ethemoğlu Ö; Boz C; Gümüş H; Kılıç AK; Kısabay A; Bir LS; Turan ÖF; Soysal A; Köseoğlu M; Tekgöl Uzuner G; Bayındır H; Canbaz Kabay S; Çam M; Yayla V; Tan H; Özcan A; Taşkapıoğlu Ö; Korkmaz M; Tamam Y; İnanç Y; Efendi H; Kotan D; Yetkin MF; Bilgiç AB; Saçmacı H; Demirci S; Çelik Y; Poyraz T; Terzi M
    Balkan Med J; 2024 Jul; 41(4):272-279. PubMed ID: 38828767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
    Kezuka T; Usui Y; Yamakawa N; Matsunaga Y; Matsuda R; Masuda M; Utsumi H; Tanaka K; Goto H
    J Neuroophthalmol; 2012 Jun; 32(2):107-10. PubMed ID: 22157536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity - No.
    Cobo-Calvo A; Marignier R
    Mult Scler; 2020 Mar; 26(3):274-276. PubMed ID: 31842679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
    Yang Y; Huang DH; Wu L; Wu WP
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.